Зарегистрироваться
Восстановить пароль
FAQ по входу

Kwiterovich Jr. Peter O. (ed.) The Johns Hopkins Textbook of Dyslipidemia

  • Файл формата pdf
  • размером 45,36 МБ
  • Добавлен пользователем
  • Описание отредактировано
Kwiterovich Jr. Peter O. (ed.) The Johns Hopkins Textbook of Dyslipidemia
Wolters Kluwer, 2010. — 227 p. — ISBN: 978-0781782654
The first comprehensive text on dyslipidemia from a major academic institution, this book covers all aspects of dyslipidemia as it relates to human disease, including coronary artery disease, cerebrovascular disease, peripheral vascular disease, and pancreatitis. The material is presented in a clinician-friendly format and includes references for additional reading. Reflecting current guidelines from the National Cholesterol Education Program, the book explains why, when, and how to treat dyslipidemia. Coverage includes dietary treatment, drug treatment, and recommendations for special populations such as patients with coronary heart disease, patients at high risk for coronary heart disease, patients with diabetes, women, older adults, young adults, and racial and ethnic groups.
Lipid, Apolipoprotein, and Lipoprotein Metabolism: Implications for the Diagnosis of Dyslipidemia
Measurement of Lipids, Lipoproteins, and Apolipoproteins
Pathogenesis of Atherosclerosis and the Unstable Plaque
Pathophysiology and Vascular Biology of Atherosclerosis
Clinical Trial Evidence for Treatment of Dyslipidemia in the Prevention of Cardiovascular Disease
Use of Noninvasive Methods to Diagnose Cardiovascular Disease in Dyslipidemic Patients
Disorders of Hypertriglyceridemia
Disorders of LDL Metabolism
Disorders of HDL Metabolism
Pathophysiology and Treatment of Dyslipidemia in Diabetes
Dyslipidemia in Renal Disease
Dyslipidemia in Children and Adolescents
Dyslipidemia and Atherosclerosis in Women
Dyslipidemia in the Elderly: Special Insights to Inform the Management Strategy
Clinical Utility of Inflammatory Markers
ApoB and the Atherogenic ApoB Dyslipoproteinemias
Other Nontraditional Risk Factors for Cardiovascular Disease
Lipoprotein (A): A Pleotrophic Risk Factor for Cardiovascular Disease
Dietary Treatment of Dyslipidemia
Trans Fatty Acids, Dyslipidemia, and Cardiovascular Disease
Fish Oils in the Treatment of Dyslipidemia and Cardiovascular Disease
Effect of Exercise on Dyslipidemia
Pharmacologic Treatment of Dyslipidemia and Cardiovascular Disease
Therapeutic Options for Modifying Obesity and Cardiometabolic Risk Factors
  • Чтобы скачать этот файл зарегистрируйтесь и/или войдите на сайт используя форму сверху.
  • Регистрация